These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34478585)

  • 1. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
    He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
    FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells.
    Yin W; Xu J; Mao Y
    Biochem Cell Biol; 2021 Jun; 99(3):322-329. PubMed ID: 34038188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma.
    Xue C; Tian Y; Zhang J; Zhao Y; Zhan J; Fang W; Zhang L
    Drug Des Devel Ther; 2016; 10():1299-306. PubMed ID: 27099475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
    Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
    Liu D; Zhang W; Liu X; Qiu R
    Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
    Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
    Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma.
    Yang Q; Nie YH; Cai MB; Li ZM; Zhu HB; Tan YR
    Drug Des Devel Ther; 2022; 16():1191-1198. PubMed ID: 35502425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis comparing the efficacy and safety of gemcitabine plus cisplatin induction chemotherapy in patients with locoregionally advanced NPC.
    Xiao L; Kang W; Liao J; Li Y
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2441-2450. PubMed ID: 34410469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.
    Zang J; Xu M; Li C; Zhao L; Luo S; Wang J; Shi M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2369-2378. PubMed ID: 32363479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Wu M; Ou D; He X; Hu C
    Oral Oncol; 2017 Oct; 73():118-123. PubMed ID: 28939063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.
    Luo F; Lu FT; Qiu MZ; Zhou T; Ma WJ; Luo M; Zeng KM; Luo QY; Pan WT; Zhang L; Xia ZF; Zhang ZH; Cao JX; Zhao HY; Zhang L; Yang DJ
    Cell Death Dis; 2021 Aug; 12(8):772. PubMed ID: 34354046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
    Chan SK; Chan SY; Tong CC; Lam KO; Kwong DL; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
    Oral Oncol; 2021 Mar; 114():105158. PubMed ID: 33508707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
    Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
    Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Samankul A; Senawong G; Utaiwat S; Prompipak J; Woranam K; Phaosiri C; Sripa B; Senawong T
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.